Literature DB >> 14671192

Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance.

Nicola Abate1, Lucia Carulli, Alberto Cabo-Chan, Manisha Chandalia, Peter G Snell, Scott M Grundy.   

Abstract

Genetic susceptibility may be responsible for high prevalence of insulin resistance in Asian Indians. This study was carried out in samples of local Asian Indians and Caucasians to determine whether plasma cell membrane glycoprotein (PC)-1 K121Q and insulin receptor substrate-1 (IRS-1) G972A polymorphisms contribute significantly to susceptibility to insulin resistance in Asian Indians. The frequency of carrying at least one copy of the PC-1 121Q variant in Asian Indians was significantly higher than that in Caucasians (P = 0.01), but the frequency was similar for IRS-1 972A (6% and 7%). A significantly higher insulin area under the curve during oral glucose tolerance testing (P < 0.0001) and lower insulin sensitivity during hyperinsulinemic-euglycemic clamps (P = 0.04) were found in Asian Indians with PC-1 121Q variant compared with Asian Indians with wild-type PC-1 and with Caucasians with or without the polymorphism. IRS-1 972A was not associated with any change in insulin sensitivity. We conclude that the PC-1 K121Q polymorphism associates with primary insulin resistance in migrant Asian Indians. A relatively high frequency of this polymorphism thus may be one factor contributing to insulin resistance susceptibility in Asian Indians. This finding indicates the need for expanded studies on the association between PC-1 K121Q and insulin resistance in a representative sample of the Asian Indian population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14671192     DOI: 10.1210/jc.2003-030453

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Association of the Q121 variant of ENPP1 gene with decreased kidney function among patients with type 2 diabetes.

Authors:  Salvatore De Cosmo; Antonio Minenna; Yuan-Yuan Zhang; Ryan Thompson; Robert Thompson; Giuseppe Miscio; Monica Vedovato; Anna Rauseo; Alois Saller; Sandra Mastroianno; Fabio Pellegrini; Roberto Trevisan; Paola Fioretto; Alessandro Doria; Vincenzo Trischitta
Journal:  Am J Kidney Dis       Date:  2008-10-31       Impact factor: 8.860

2.  The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention.

Authors:  K Müssig; M Heni; C Thamer; K Kantartzis; F Machicao; N Stefan; A Fritsche; H-U Häring; H Staiger
Journal:  Diabetologia       Date:  2009-11-29       Impact factor: 10.122

3.  New Insights into the Role of ENPP1 in Insulin Resistance.

Authors:  Wentong Pan; Manisha Chandalia; Nicola Abate
Journal:  J Metabonomics Metab       Date:  2012-10-15

4.  Fasting glucose GWAS candidate region analysis across ethnic groups in the Multiethnic Study of Atherosclerosis (MESA).

Authors:  Laura J Rasmussen-Torvik; Xiuqing Guo; Donald W Bowden; Alain G Bertoni; Michele M Sale; Jie Yao; David A Bluemke; Mark O Goodarzi; Y Ida Chen; Dhananjay Vaidya; Leslie J Raffel; George J Papanicolaou; James B Meigs; James S Pankow
Journal:  Genet Epidemiol       Date:  2012-04-16       Impact factor: 2.135

5.  The ENPP1 K121Q polymorphism is not associated with type 2 diabetes and related metabolic traits in an Iranian population.

Authors:  Hamzeh Saberi; Narges Mohammadtaghvaei; Shekufeh Gulkho; Salar Bakhtiyari; Mohammad Mohammadi; Parichehr Hanachi; Siavash Gerayesh-Nejad; Mehryar Zargari; Farangis Ataei; Leila Parvaneh; Bagher Larijani; Reza Meshkani
Journal:  Mol Cell Biochem       Date:  2010-12-14       Impact factor: 3.396

6.  The K121Q polymorphism of ENPP1 and peripheral arterial disease.

Authors:  Philipp Eller; Wilfried Schgoer; Thomas Mueller; Ivan Tancevski; Egon Demetz; Kristina Duwensee; Andreas Ritsch; Meinhard Haltmayer; Josef R Patsch
Journal:  Heart Vessels       Date:  2008-04-04       Impact factor: 2.037

7.  ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population.

Authors:  Miao-Pei Chen; Fu-Mei Chung; Dao-Ming Chang; Jack C-R Tsai; Han-Fen Huang; Shyi-Jang Shin; Yau-Jiunn Lee
Journal:  Rev Diabet Stud       Date:  2006-05-10

8.  Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women.

Authors:  Steve E Humphries; David Gable; Jackie A Cooper; Helen Ireland; Jeffrey W Stephens; Steven J Hurel; Ka Wah Li; Jutta Palmen; Michelle A Miller; Francesco P Cappuccio; Robert Elkeles; Ian Godsland; George J Miller; Philippa J Talmud
Journal:  J Mol Med (Berl)       Date:  2006-12       Impact factor: 4.599

9.  Genetic risk factors for type 2 diabetes with pharmacologic intervention in African-American patients with schizophrenia or schizoaffective disorder.

Authors:  M R Irvin; H W Wiener; R P Perry; R M Savage; R C P Go
Journal:  Schizophr Res       Date:  2009-07-29       Impact factor: 4.939

Review 10.  The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.

Authors:  Ira D Goldfine; Betty A Maddux; Jack F Youngren; Gerald Reaven; Domenico Accili; Vincenzo Trischitta; Riccardo Vigneri; Lucia Frittitta
Journal:  Endocr Rev       Date:  2008-01-16       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.